| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 9.695 | 52.022 | 4.199 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 0 | 9.695 | 52.022 | 4.199 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 253 | 6.980 | 12.614 | 5.748 | 791 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | -253 | 2.715 | 39.408 | -1.550 | -791 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | -253 | 2.424 | 37.847 | -1.676 | -791 | 0 | 0 | 0 | 0 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medical Respiromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.135 | 2.093 | 1.873 | 356 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 76 | 7.078 | 40.749 | 2.773 | 2.202 | 2.154 | 2.160 | 2.154 | 2.142 |
| Inventories | - | 0 | 947 | 929 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 527 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 76 | 6.131 | 39.819 | 2.246 | 2.202 | 2.154 | 2.160 | 2.154 | 2.142 |
| Shareholders Funds | - | -209 | 2.219 | 40.025 | 2.783 | 1.940 | 1.897 | 1.903 | 1.897 | 1.886 |
| Social Capital | - | 45 | 44 | 43 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 2.420 | 6.951 | 2.597 | 346 | 263 | 257 | 258 | 257 | 256 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medical Respiromed Srl